In CZTSSe solar cells,a simple sodium-incorporation post-treatment method toward solution-processed Cu2Zn Sn S4precursor films is presented in this work.An ultrathin NaCl film is deposited on Cu2Zn Sn S4precursor film...In CZTSSe solar cells,a simple sodium-incorporation post-treatment method toward solution-processed Cu2Zn Sn S4precursor films is presented in this work.An ultrathin NaCl film is deposited on Cu2Zn Sn S4precursor films by spin-coating NaCl solution.In subsequent selenization process,the introduction of Na Cl is found to be benefacial for the formation of Cu2-xSe,which can further facilitate the element transportation,leading to dense and smooth CZTSSe films with large grains and less impurity Cu2Sn(S,Se)3phase.SIMS depth profiles confirm the gradient distribution of the sodium element in Na-doped absorbers.Photoluminescence spectra show that the introduction of appropriate sodium into the absorber can inhibit the band tail states.As high as 11.18% of power conversion efficiency(PCE)is achieved for the device treated with 5 mg mL^-1 NaCl solution,and an average efficiency of Na-doped devices is 10.71%,13%higher than that of the control groups(9.45%).Besides,the depletion width and the charge recombination lifetime can also have regular variation with sodium treatment.This work offers an easy modification method for high-quality Na-doped CZTSSe films and high-performance devices,in the meantime,it can also help to further understand the effects of sodium in CZTSSe solar cells.展开更多
The most common and aggressive type of brain tumor is glioblastoma multiforme (GBM). The prognosis for GBM remains poor with a five-year survival rate between 1% and 2%. The prospects for patients with recurrent GBM (...The most common and aggressive type of brain tumor is glioblastoma multiforme (GBM). The prognosis for GBM remains poor with a five-year survival rate between 1% and 2%. The prospects for patients with recurrent GBM (RGBM) are much worse, with the majority dying within 6 months. This publication provides a brief description of the treatment of 11 GBM patients treated with sodium phenylbutyrate (PB) in combination with pazopanib, m-TOR inhibitors, and other agents. The treatment was associated with tolerable side effects and resulted in objective responses in 54.5% of cases (complete response 18.2%, partial response 36.3%) and 27.3% cases of stable disease. The preferable treatment regimen consisted of PB, pazopanib, dasatinib, everolimus, and bevacizumab (BVZ). For various reasons not all patients were compliant with the treatment regimen. In patients who strictly complied with the treatment plan, all responded as CR or PR. Based on preliminary findings, the authors propose further phase I/II clinical trials with PB in combination with pazopanib, dasatinib, everolimus, and BVZ in patients with RGBM who failed standard surgery, radiation therapy and chemotherapy. With proper dose reductions, the treatment appears to be well-tolerated. Molecular profiling of patient subgroups with favorable genomic signatures may help to select patients for future studies.展开更多
A new and effective strategy was proposed for preparing new organic-inorganic composite biosorbent with spherical silica as supporting core and chitosan（CS）-based hybrid layer as shell based on sol-gel reaction and ...A new and effective strategy was proposed for preparing new organic-inorganic composite biosorbent with spherical silica as supporting core and chitosan（CS）-based hybrid layer as shell based on sol-gel reaction and simple treatment with sodium hydroxide（NaOH）. The coating layer was covalently bound on the supporting silica through polysaccharide incorporated sol-gel process starting from CS and inorganic precursor γ-glycidoxypropyltrimethoxysiloxane（GPTMS）. GPTMS had epoxide groups and cross-linked amine groups of CS to avoid its acidic solubilization. The composite biosorbent had coarse surface due to the wet phase-inversion by treating in NaOH solution. The prepared biosorbent could be used in treating electric plating wastewater.展开更多
Sodium beta alumina（Na-β-alumina） films were synthesized by heat treatment of NaAl6O（9.5）and γ-NaA1O2 films at temperatures of 1 373-1 573 K.Single-phase γ-NaA1O2 and NaAl6O（9.5） films were prepared by laser ...Sodium beta alumina（Na-β-alumina） films were synthesized by heat treatment of NaAl6O（9.5）and γ-NaA1O2 films at temperatures of 1 373-1 573 K.Single-phase γ-NaA1O2 and NaAl6O（9.5） films were prepared by laser chemical vapor deposition at the deposition temperatures of 976 and 1 100 K,respectively.Subsequent heat treatment of the films resulted in the formation of Na-β-alumina with α-Al2O3 at temperatures above 1 373 K for NaAl6O（9.5） and 1 473 K for γ-NaA1O2.On heat treatment at temperatures of 1 473-1 573 K,the faceted morphology with terraces of the as-deposited（110）-oriented γ-NaAlO2 films transformed to a porous morphology with platelet grains comprising Na-β-alumina and α-Al2O3.On heat treatment at temperatures of1 373-1 473 K,the pyramidal,faceted grains of as-deposited NaAl6O（9.5） films transformed to planer,shapeanisotropic morphology in the film of mixed Na-β-alumina and α-Al2O3.A dense morphology was observed in both the as-deposited and heat-treated NaAl6O（9.5） films.展开更多
Firstly, the water-quality characteristics of intestinal lavage wastewater and enzymolysis wastewater from the typical heparin sodium pro- ductive process were analyzed, and then the segregation treatment was applied ...Firstly, the water-quality characteristics of intestinal lavage wastewater and enzymolysis wastewater from the typical heparin sodium pro- ductive process were analyzed, and then the segregation treatment was applied in the treatment of enteric coating and heparin sodium manufacturing wastewater. Finally, the treatment of the two kinds of wastewater by different methods were discussed. The results showed that, COD of enzymolysis wastewater treated by centrifugation-coagulation-Fenton reagent oxidation-adsorption process was lower than 100 mg/L, while intestinal lavage wastewater treated by coagulation-ASBR-SBR process could meet the first standard of Comprehensive Discharge Standard of Sewage （GB8978-1996） after one month of continuous operation.展开更多
基金financially supported by the National Natural Science Foundation of China (Nos. 51421002, 51627803, 91733301, 51761145042, 21501183, 51402348, 53872321, and 11874402)the Knowledge Innovation Program and the Strategic Priority Research Program (Grant XDB 12010400) of the Chinese Academy of Sciences
文摘In CZTSSe solar cells,a simple sodium-incorporation post-treatment method toward solution-processed Cu2Zn Sn S4precursor films is presented in this work.An ultrathin NaCl film is deposited on Cu2Zn Sn S4precursor films by spin-coating NaCl solution.In subsequent selenization process,the introduction of Na Cl is found to be benefacial for the formation of Cu2-xSe,which can further facilitate the element transportation,leading to dense and smooth CZTSSe films with large grains and less impurity Cu2Sn(S,Se)3phase.SIMS depth profiles confirm the gradient distribution of the sodium element in Na-doped absorbers.Photoluminescence spectra show that the introduction of appropriate sodium into the absorber can inhibit the band tail states.As high as 11.18% of power conversion efficiency(PCE)is achieved for the device treated with 5 mg mL^-1 NaCl solution,and an average efficiency of Na-doped devices is 10.71%,13%higher than that of the control groups(9.45%).Besides,the depletion width and the charge recombination lifetime can also have regular variation with sodium treatment.This work offers an easy modification method for high-quality Na-doped CZTSSe films and high-performance devices,in the meantime,it can also help to further understand the effects of sodium in CZTSSe solar cells.
文摘The most common and aggressive type of brain tumor is glioblastoma multiforme (GBM). The prognosis for GBM remains poor with a five-year survival rate between 1% and 2%. The prospects for patients with recurrent GBM (RGBM) are much worse, with the majority dying within 6 months. This publication provides a brief description of the treatment of 11 GBM patients treated with sodium phenylbutyrate (PB) in combination with pazopanib, m-TOR inhibitors, and other agents. The treatment was associated with tolerable side effects and resulted in objective responses in 54.5% of cases (complete response 18.2%, partial response 36.3%) and 27.3% cases of stable disease. The preferable treatment regimen consisted of PB, pazopanib, dasatinib, everolimus, and bevacizumab (BVZ). For various reasons not all patients were compliant with the treatment regimen. In patients who strictly complied with the treatment plan, all responded as CR or PR. Based on preliminary findings, the authors propose further phase I/II clinical trials with PB in combination with pazopanib, dasatinib, everolimus, and BVZ in patients with RGBM who failed standard surgery, radiation therapy and chemotherapy. With proper dose reductions, the treatment appears to be well-tolerated. Molecular profiling of patient subgroups with favorable genomic signatures may help to select patients for future studies.
基金Supported by the National Natural Science Foundation of China(Nos.20775039 and 20602009)the Natural Science Founda-tion of Shandong Province of China(No.ZR2009BM031 and Q2008B05)+1 种基金the Public Welfare Project of Marine Science Research of China(Nos.200705011 and 200805039)the Science Research Fund of the First Institute of Oceanograph of China
文摘A new and effective strategy was proposed for preparing new organic-inorganic composite biosorbent with spherical silica as supporting core and chitosan（CS）-based hybrid layer as shell based on sol-gel reaction and simple treatment with sodium hydroxide（NaOH）. The coating layer was covalently bound on the supporting silica through polysaccharide incorporated sol-gel process starting from CS and inorganic precursor γ-glycidoxypropyltrimethoxysiloxane（GPTMS）. GPTMS had epoxide groups and cross-linked amine groups of CS to avoid its acidic solubilization. The composite biosorbent had coarse surface due to the wet phase-inversion by treating in NaOH solution. The prepared biosorbent could be used in treating electric plating wastewater.
基金Funded by the Ministry of Education,Culture,Sports,Science and Technology,a Grant-in-Aid for Challenging Exploratory Research(No.26560235)the ARCMG–IMR Cooperative Program(No.14G0402)of Tohoku Universitythe China Scholarship Council and the 111 Project(No.B13035)of China
文摘Sodium beta alumina（Na-β-alumina） films were synthesized by heat treatment of NaAl6O（9.5）and γ-NaA1O2 films at temperatures of 1 373-1 573 K.Single-phase γ-NaA1O2 and NaAl6O（9.5） films were prepared by laser chemical vapor deposition at the deposition temperatures of 976 and 1 100 K,respectively.Subsequent heat treatment of the films resulted in the formation of Na-β-alumina with α-Al2O3 at temperatures above 1 373 K for NaAl6O（9.5） and 1 473 K for γ-NaA1O2.On heat treatment at temperatures of 1 473-1 573 K,the faceted morphology with terraces of the as-deposited（110）-oriented γ-NaAlO2 films transformed to a porous morphology with platelet grains comprising Na-β-alumina and α-Al2O3.On heat treatment at temperatures of1 373-1 473 K,the pyramidal,faceted grains of as-deposited NaAl6O（9.5） films transformed to planer,shapeanisotropic morphology in the film of mixed Na-β-alumina and α-Al2O3.A dense morphology was observed in both the as-deposited and heat-treated NaAl6O（9.5） films.
基金Supported by the Project of Practical Innovation Training Program of Undergraduates in Jiangsu Province in 2012(232)
文摘Firstly, the water-quality characteristics of intestinal lavage wastewater and enzymolysis wastewater from the typical heparin sodium pro- ductive process were analyzed, and then the segregation treatment was applied in the treatment of enteric coating and heparin sodium manufacturing wastewater. Finally, the treatment of the two kinds of wastewater by different methods were discussed. The results showed that, COD of enzymolysis wastewater treated by centrifugation-coagulation-Fenton reagent oxidation-adsorption process was lower than 100 mg/L, while intestinal lavage wastewater treated by coagulation-ASBR-SBR process could meet the first standard of Comprehensive Discharge Standard of Sewage （GB8978-1996） after one month of continuous operation.
